Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 Medical Device Investing
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma Pharmaceutical Investing
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma Pharmaceutical Investing
Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs Pharmaceutical Investing
AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates Biotech Investing
